Back

Role of dysregulated aldosterone in hypertension

31 August 2025 (15:30 - 15:40)
Organised by: Logo
Congress Presentation Part of: Targeting dysregulated aldosterone in uncontrolled and treatment resistant hypertension with a novel aldosterone synthase inhibitor, lorundrostat Hypertension Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Rhian Touyz

Mcgill University, Montreal (Canada)

4 More presentations in this session

Presentation thumbnail
Welcome and introductions
Doctor M. Saxena (London, GB) Professor R. Touyz (Montreal, CA) Professor L. Vogt (Amsterdam, NL)
Presentation thumbnail
Unmet clinical need in uncontrolled and treatment resistant hypertension
Professor L. Vogt (Amsterdam, NL)
Presentation thumbnail
Targeting unmet clinical need with a novel aldosterone synthase inhibitor lorundrostat
Doctor M. Saxena (London, GB)
Presentation thumbnail
Panel discussion and audience Q&A
Professor R. Touyz (Montreal, CA) Doctor M. Saxena (London, GB) Professor L. Vogt (Amsterdam, NL)

Access the full session

Session thumbnail
Targeting dysregulated aldosterone in uncontrolled and treatment resistant hypertension with a novel aldosterone synthase inhibitor, lorundrostat

The Event

Event poster

ESC Congress 2025

31 August 2025 15:30 CET
You may be interested in
thumbnail
Webinar
Management of blood pressure: selected case-based advice
thumbnail
Congress Session
Arterial hypertension
thumbnail
Congress Presentation
Highlights from the 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources